Arvinas ARVN
NASDAQ ARVN
$9.35 +0.04 (+0.43%)
As of: Sep 4, 2026 · 2:27 PM EDT

Arvinas (ARVN) Net Cash Flow (2017 - 2026)

Arvinas (ARVN) posted quarterly Net Cash Flow of -$55.6 million for Q1 2026, down 185.13% year-over-year from $65.3 million in Q1 2025, and down 234.3% quarter-over-quarter from $41.4 million in Q4 2025.

Analysis

Arvinas (ARVN) Net Cash Flow (2017 - 2026) Analysis & Trends

Arvinas' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$55.6 million for Q1 2026.

  • In Q1 2026, Net Cash Flow fell 185.13% year-over-year to -$55.6 million; the TTM figure through Mar 2026 stood at $6.3 million (up 150.4% YoY), while the FY2025 annual figure was $42.4 million, up 119.57% from the prior year.
  • Net Cash Flow for Q1 2026 stood at -$55.6 million, down from $41.4 million in the prior quarter.
  • The five-year high for Net Cash Flow was $198.0 million in Q4 2023, with the low at -$223.7 million in Q1 2024.
  • The 5-year median for Net Cash Flow is $15.3 million (2024), against an average of -$1.5 million.
  • The sharpest annual moves came in 2023 and 2024: Net Cash Flow soared 485.96% in 2023, then sank 557.46% in 2024.
  • Arvinas' Net Cash Flow stood at -$51.3 million in 2022, then jumped by 485.96% to $198.0 million in 2023, then tumbled by 92.27% to $15.3 million in 2024, then surged by 170.59% to $41.4 million in 2025, then plunged by 234.3% to -$55.6 million in 2026.
  • Business Quant data shows ARVN's Net Cash Flow at -$55.6 million in Q1 2026, $41.4 million in Q4 2025, and -$13.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 374.50 Mn
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.41 Bn 27.57 Bn - 225.59 Mn
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn -37.14 Mn
10 Arvinas 605.88 Mn 37.98 Mn - 7.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.00 Mn
Mar 31, 2026 -55.60 Mn
Dec 31, 2025 41.40 Mn
Sep 30, 2025 -13.40 Mn
Jun 30, 2025 33.90 Mn
Mar 31, 2025 -19.50 Mn
Dec 31, 2024 15.30 Mn
Sep 30, 2024 -75.10 Mn
Jun 30, 2024 66.80 Mn
Mar 31, 2024 -223.70 Mn
Dec 31, 2023 198.00 Mn
Sep 30, 2023 23.10 Mn
Jun 30, 2023 -39.60 Mn
Mar 31, 2023 48.90 Mn
Dec 31, 2022 -51.30 Mn
Sep 30, 2022 40.40 Mn
Jun 30, 2022 30.90 Mn
Mar 31, 2022 -46.00 Mn
Dec 31, 2021 -147.40 Mn
Sep 30, 2021 207.00 Mn